Lidocaine Subcutaneous Infusion for Control of Treprostinil Related Site Pain

This study has been terminated.
(Safety considerations)
Sponsor:
Information provided by (Responsible Party):
Dr David Langleben, Jewish General Hospital
ClinicalTrials.gov Identifier:
NCT01433328
First received: September 9, 2011
Last updated: April 4, 2012
Last verified: April 2012
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: April 2012
  Primary Completion Date: March 2012 (Final data collection date for primary outcome measure)